US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
DocMorris AG (0RRB) 銘柄情報

DocMorris AG (0RRB)

123.60

0.00

(0.00%)

終了 7月10日 12:30AM

DocMorris AG (0RRB) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

123.60

( - )

買値

123.60

売値

123.60

出来高

44,215

平均取引量 (3 か月)

CHF 312,938

財務取引量

-

0.00 日の範囲 0.00

123.60 52 週間の範囲 123.60

時価総額

企業価値

573.559M

前日終値

123.60

始値

-

時刻

最終取引時間

VWAP

-

歳入

1.12B

純利益

-134.4M

発行済株式数

48,106,618

浮動株比率 (%)

72.87%

機関投資家保有比率 (%)

33.68%

配当利回り

PER

-2.62

株価売上高倍率 (PSR)

0.4

1 株当たり利益 (EPS)

-3.47

ベータ

1.86

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and ... DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

corporate.docmorris.com

本社

Frauenfeld, Switzerland

設立

1993

DocMorris AG is listed in the sector of the ロンドン証券取引所 with ticker 0RRB. The last closing price for DocMorris was CHF123.60. Over the last year, DocMorris shares have traded in a share price range of CHF 123.60 to CHF 123.60.

DocMorris currently has 48,106,618 shares in issue. The market capitalisation of DocMorris is CHF5.95 billion. DocMorris has a price to earnings ratio (PE ratio) of -2.62.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	123.6	123.6	123.6	17835	123.6	DE
52	0	0	123.6	123.6	123.6	18394	123.6	DE
156	0	0	123.6	123.6	123.6	11568	123.6	DE
260	0	0	123.6	123.6	123.6	12367	123.6	DE

0RRB - Frequently Asked Questions (FAQ)

What is the current DocMorris AG share price?

The current share price of DocMorris AG is CHF 123.60

How many DocMorris AG shares are in issue?

DocMorris AG has 48,106,618 shares in issue

What is the market cap of DocMorris AG?

The market capitalisation of DocMorris AG is CHF 5.95B

What is the 1 year trading range for DocMorris AG share price?

DocMorris AG has traded in the range of CHF 123.60 to CHF 123.60 during the past year

What is the PE ratio of DocMorris AG?

The price to earnings ratio of DocMorris AG is -2.62

What is the cash to sales ratio of DocMorris AG?

The cash to sales ratio of DocMorris AG is 0.4

What is the registered address of DocMorris AG?

The registered address for DocMorris AG is WalzmUehlestrasse 49, Frauenfeld, Thurgau, 8500

What is the DocMorris AG website address?

The website address for DocMorris AG is corporate.docmorris.com/en

88TH MAN

88TH MAN 2分前

Holding all my shares. BULLISH!!!

DJknows

DJknows 2分前

I was supposed to quit for the night with the last post but thought I'd check out Mr. Taylor's LinkedIn and found the following:

https://www.linkedin.com/in/rodolfo-taylor-07b32791/recent-activity/all/

Rodolfo Taylor
Automotive Professional Consultant. Sp

ghostandgurgi

ghostandgurgi 2分前

Even 1-100 split only gets this to $3 and they need $4 to uplist, so not sure how they plan to get there.

johnydollar

johnydollar 3分前

Sometimes i wonder how old some people are...........

Online........

Am sure some do have snot running down their nose.......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆

Hey_Its_That_Guy

Hey_Its_That_Guy 5分前

Because you touch yourself at night

biotech_researcher

biotech_researcher 8分前

Well, most of have reached the 3.5 year point from our last shot, so we can be confident that the vaccine has cleared. What’s the point of this article?

johnydollar

johnydollar 8分前

For a minute there i thought about lucky Gilmore..........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

Jetmek_03052

Jetmek_03052 8分前

88TH MAN

88TH MAN 9分前

Buy, buy, buy... Hold, hold, hold... Profit, profit, profit. BULLISH!!!

Porch Honkey

Porch Honkey 9分前

Nonsense, lol. Craig Marshak holds the Wertheim trademark name and sits on your company's board as a private director of that company, per se, lmao!

samson8

samson8 11分前

500 million more shares added today

88TH MAN

88TH MAN 11分前

Charles Schwab shows $0.10. The chart on E*Trade shows $0.10. I am convinced $0.10 is the true price. I had an order to Sell at $0.10. At this point, I will not sell for less than $0.10. BULLISH!!!

SkiMan85

SkiMan85 13分前

I think GetRch$lwly laid out a reasonable “everything goes perfectly” scenario, but I still think it’s probably too optimistic.

NAMSA absolutely improves the odds of getting the IDE right the first time, but it doesn’t eliminate FDA review timelines or potential questions. They still

DrivenByPain

DrivenByPain 14分前

🤑SNTX🤑 You All Ready To See A Million + In Your Accounts $🤑$🤑$🤑$🤑$🤑$🤑$🤑Elon Be Liking Mr Leal !

KeepItRealistic

KeepItRealistic 16分前

$OSRH what is there not to like 💎
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

KeepItRealistic

KeepItRealistic 17分前

$OSRH what is there not to like 💎
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

Kentucky123

Kentucky123 18分前

I know most do not follow charts and think they are useless for low cap bio. They have been right for the last five years. In order for that to change I believe we need to see volume of 10 million shares on big news. Here is the chart.
https://schrts.co/mHVrctPW

hankmanhub

hankmanhub 18分前

• “…recognizing the impact this medicine could potentially have.”
This could be true of every single treatment that is up for approval, as a new treatment not yet available prior to approval,

Guido2

Guido2 25分前

https://x.com/GuidoPerei/status/2075395630298804549?s=20

DJknows

DJknows 27分前

One new comment on today's The Luminary Live program from Rodolfo Taylor:

https://www.linkedin.com/in/robertblum/recent-activity/comments/

Rodolfo Taylor
Automotive Professional Consultant. Specializing in Next-Gen Mobility, Advancing the Transition from Copper t

Guido2

Guido2 27分前

https://x.com/GuidoPerei/status/2075395630298804549?s=20

US Market News

US Market News 28分前

Australian Firms Shift Cybersecurity Focus to ResilienceJuly 9, 2026 9:43 PM
Business Wire Organizations seek partners with local capabilities, including AI risk management and regulatory readiness, ISG Provider Lens® report says Enterprises

Goats'nCrows

Goats'nCrows 30分前

barnstormer, are you okay? Marnix Bosch is one person. Not being facetious, do you feel okay?

Momentum_Scalper

Momentum_Scalper 30分前

Definitely getting the feeling these guys took the summer off. Hopefully not the case.

ABMIF IIArizona Portfoli...

Brucap1.5%5apr2037 Bruca...

Bofa Finance Llc Autocal...

US Dollar vs Yen

Vontobel Financial Produ...

Mountview Estates

Aavegotchi GHST Token

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。